IL156794A0 - Chemical derivatives and their use as anti-telomerase agent - Google Patents
Chemical derivatives and their use as anti-telomerase agentInfo
- Publication number
- IL156794A0 IL156794A0 IL15679402A IL15679402A IL156794A0 IL 156794 A0 IL156794 A0 IL 156794A0 IL 15679402 A IL15679402 A IL 15679402A IL 15679402 A IL15679402 A IL 15679402A IL 156794 A0 IL156794 A0 IL 156794A0
- Authority
- IL
- Israel
- Prior art keywords
- chemical derivatives
- telomerase agent
- telomerase
- agent
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0100205A FR2819255B1 (fr) | 2001-01-09 | 2001-01-09 | Derives chimiques et leur application comme agent antitelomerase |
| PCT/FR2002/000057 WO2002055515A1 (fr) | 2001-01-09 | 2002-01-09 | Derives chimiques et leur application comme agent antitelomerase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL156794A0 true IL156794A0 (en) | 2004-02-08 |
Family
ID=8858610
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15679402A IL156794A0 (en) | 2001-01-09 | 2002-01-09 | Chemical derivatives and their use as anti-telomerase agent |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1351957A1 (es) |
| JP (1) | JP2004520350A (es) |
| AU (1) | AU2002229859B2 (es) |
| CA (1) | CA2433723A1 (es) |
| FR (1) | FR2819255B1 (es) |
| IL (1) | IL156794A0 (es) |
| MX (1) | MXPA03005975A (es) |
| WO (1) | WO2002055515A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6887873B2 (en) | 2001-03-23 | 2005-05-03 | Aventis Pharma S.A. | Triazine derivatives and their application as antitelomerase agents |
| US7173032B2 (en) * | 2001-09-21 | 2007-02-06 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| FR2850970B1 (fr) * | 2003-02-07 | 2006-07-07 | Aventis Pharma Sa | Derives chimiques se liant de maniere tres specifique aux structures d'adn en g-quadruplexe et leur application comme agent anticancereux specifique |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9206768D0 (en) * | 1992-03-27 | 1992-05-13 | Jarman Michael | New compounds for use in the treatment of cancer |
| US5767278A (en) * | 1995-10-06 | 1998-06-16 | Geron Corporation | Telomerase inhibitors |
| JPH1160573A (ja) * | 1997-08-22 | 1999-03-02 | Nippon Kayaku Co Ltd | トリアジン誘導体及びテロメラーゼ阻害剤 |
-
2001
- 2001-01-09 FR FR0100205A patent/FR2819255B1/fr not_active Expired - Fee Related
-
2002
- 2002-01-09 CA CA002433723A patent/CA2433723A1/fr not_active Abandoned
- 2002-01-09 EP EP02710956A patent/EP1351957A1/fr not_active Withdrawn
- 2002-01-09 MX MXPA03005975A patent/MXPA03005975A/es not_active Application Discontinuation
- 2002-01-09 IL IL15679402A patent/IL156794A0/xx unknown
- 2002-01-09 JP JP2002556184A patent/JP2004520350A/ja not_active Abandoned
- 2002-01-09 AU AU2002229859A patent/AU2002229859B2/en not_active Expired - Fee Related
- 2002-01-09 WO PCT/FR2002/000057 patent/WO2002055515A1/fr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA03005975A (es) | 2005-02-14 |
| WO2002055515A1 (fr) | 2002-07-18 |
| FR2819255A1 (fr) | 2002-07-12 |
| AU2002229859B2 (en) | 2008-03-13 |
| EP1351957A1 (fr) | 2003-10-15 |
| JP2004520350A (ja) | 2004-07-08 |
| FR2819255B1 (fr) | 2003-02-28 |
| CA2433723A1 (fr) | 2002-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1078266A1 (en) | Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same | |
| AUPR879601A0 (en) | Novel chemical compounds and their use | |
| MXPA03006260A (es) | Derivados de amina sustituidos y metodos de uso. | |
| ZA200300545B (en) | Novel heteroaryl derivatives and use thereof as anti-tumour agents. | |
| IL150701A0 (en) | 4-aminopicolinates and their use as herbicides | |
| AU8729901A (en) | Benzoylpyrazols and their use as herbicides | |
| AU2002358700A8 (en) | Urea derivatives as vr1- antagonists | |
| AU2002314252A1 (en) | Chemical derivatives and the use thereof as an anti-telomerase agent | |
| HUP0402025A3 (en) | Novel bensophenone derivatives or salts thereof and their use | |
| HUP0401756A3 (en) | Substituted benzimidazole compounds and their use | |
| IL158056A0 (en) | Chemical derivatives and their use as anti-telomerase agent | |
| AU2002251140A1 (en) | Chemical derivatives and their use as anti-telomerase agent | |
| GB0126889D0 (en) | Compounds and their uses | |
| AUPR879701A0 (en) | Novel chemical compounds and their use | |
| HUP0500734A3 (en) | Use of 2-alkoxyphenyl-substituted imidazotriazinones | |
| HUP0600238A3 (en) | Benzothiazole- and benzoxazole-4,7-dione derivatives and their use | |
| EP1392317A4 (en) | SUBSTITUTED 1-BENZAZEPINE AND DERIVATIVES THEREOF | |
| HK1066022A1 (en) | Use of 1,1,1,3,3-pentafluorobutan | |
| HUP0401162A3 (en) | Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives | |
| IL156794A0 (en) | Chemical derivatives and their use as anti-telomerase agent | |
| AU2002229859A1 (en) | Chemical derivatives and their use as anti-telomerase agent | |
| AU2001282268A1 (en) | Phenantridine derivatives and their use as anti-telomerase agent | |
| EP1367123A4 (en) | NEUROTONIN AND ITS USE | |
| GB0122162D0 (en) | Agent | |
| GB0106987D0 (en) | Immunotherapeuitic agent |